Generic Name and Formulations:
Allium cepa 3C HPUS, Apis mellifica 6C HPUS, Belladonna 6C HPUS, Eupatorium perfoliatum 3C HPUS, Gelsemium sempervirens 6C HPUS, Kali bichromicum 6C HPUS, Nux vomica 3C HPUS, Phytolacca decandra 6C HPUS, Pulsatilla 6C HPUS; quick-dissolving tabs.
Indications for COLDCALM:
Temporary relief of cold symptoms, such as sneezing, runny nose, nasal congestion, minor sore throat.
Adults and Children:
<3yrs: not recommended. ≥3yrs: dissolve 2 tablets in the mouth every 2 hours up to 6 times/day.
Pregnancy. Nursing mothers.
Pellets—160 (80 pellets/tube)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- A Ketogenic Diet as an Adjunct to Cancer Treatment
- Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves
- Blinatumomab-Ponatinib Salvage Therapy in B-Cell Acute Lymphoblastic Leukemia: Case Report of Benefit
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- FDA Provides Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma
- Nivolumab-Ipilimumab Survival Benefit in Advanced RCC Confirmed
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Adding Chemotherapy to Radiation Post-Radical Cystectomy Improves Survival in Urothelial Carcinoma
- Radiation, Chemotherapy Not Beneficial in Localized Upper Tract Urothelial Carcinoma
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer